Products from TargetMol

TargetMol

TargetMol, based in Boston, Massachusetts, was founded in 2015 and is a drug screening expert in the life science community. The company offers diverse compound libraries, including FDA-approved libraries, and covers a broad spectrum of small molecule compounds such as inhibitors and agonists as well as recombinant proteins and natural products. TargetMol's products are used by researchers worldwide in areas such as cancer research, neurobiology, inflammation, immunology and metabolism.

More information at: www.targetmol.com

Go to the catalogs of TargetMol

12272 from 12310 pages
No results were found for the filter!
Antitumor agent-42
Antitumor agent-42

Item number: TGM-T64071-100mg

Description: Antitumor agent-42 inhibits microtubule multimerisation and NO release, exhibiting anti-angiogenic, colony-forming and apoptosis-inducing effects. Target: Others
MW: 575.39 D
From 1,440.00€ *
Review
BACE1-IN-8
BACE1-IN-8

Item number: TGM-T64074-100mg

Description: BACE1-IN-8 is a potent inhibitor of BACE1 (beta-site APP lyase 1) (IC50: 3.9 µM). Target: Others
MW: 575.7 D
From 1,440.00€ *
Review
MRS2179 tetrasodium hydrate
MRS2179 tetrasodium hydrate

Item number: TGM-T64078-100mg

Description: MRS2179 tetrasodium hydrate, a competitive antagonist of the P2Y1 receptor, acts on the turkey P2Y1 receptor (Kb: 102 nM, pA2: 6.99) and exhibits an inhibitory effect on platelet aggregation. IC50: 1.15 µM), P2X3 (IC50: 12.9 µM), P2X2, P2X4, P2Y2, P2Y4 and P2Y6 receptors. Target: Others
MW: 576.21 D
From 1,279.00€ *
Review
BPN-15606 besylate
BPN-15606 besylate

Item number: TGM-T64081-100mg

Description: BPN-15606 besylate is a potent, orally active gamma-secretase regulator (GSM) that reduces the production of Abeta42 (IC50: 7 nM) and Abeta40 (IC50: 17 nM) by SHSY5Y neuroblastoma cells. BPN-15606 besylate exhibited good PK/PD properties (including bioavailability, half-life and clearance). Target: Others
MW: 576.64 D
From 1,440.00€ *
Review
Lafadofensine (D-(-)-Mandelic acid)
Lafadofensine (D-(-)-Mandelic acid)

Item number: TGM-T64088-100mg

Description: Lafadofensine D-(-)-Mandelic acid is a monoamines reuptake inhibitor with sufficient efficacy for short-term administration. Target: Others
MW: 578.6 D
From 1,023.00€ *
Review
BRD4 D1-IN-1
BRD4 D1-IN-1

Item number: TGM-T64089-100mg

Description: BRD4 D1-IN-1 is a selective inhibitor of BRD4 D1 with an IC50 <0.092 µM, an affinity of 18 nM, and over 500-fold selectivity for BRD4 D1 and BRD4 D2. Target: Others
MW: 578.67 D
From 1,440.00€ *
Review
KRAS G12C inhibitor 44
KRAS G12C inhibitor 44

Item number: TGM-T64093-100mg

Description: KRAS G12C inhibitor 44 is a potent, orally active KRAS G12C inhibitor. KRAS G12C inhibitor 44 exhibits anti-proliferative effects in MIA PaCA-2 (IC50: 0.016 µM), H358 cells (IC50: 0.028 µM). inhibitor 44 has anti-tumour activity in vivo. Target: Others
MW: 579.11 D
From 1,440.00€ *
Review
FXIa-IN-10
FXIa-IN-10

Item number: TGM-T64098-100mg

Description: FXIa-IN-10 is a potent, orally bioavailable inhibitor of Activator XI (FXIa) (Ki: 0.17 nM). Target: Others
MW: 580.35 D
From 1,440.00€ *
Review
FTI-2153 TFA
FTI-2153 TFA

Item number: TGM-T64101-25mg

Description: FTI-2153 TFA is a highly selective and potent inhibitor of the farnesyltransferase (FTase) enzyme (IC50: 1.4 nM). The inhibition activity was more than 3000 times that of Rap1A protein processing. Target: Others
MW: 580.62 D
From 1,421.00€ *
Review
JAK2/FLT3-IN-1 TFA
JAK2/FLT3-IN-1 TFA

Item number: TGM-T64104-25mg

Description: JAK2/FLT3-IN-1 (TFA) is an orally active dual inhibitor of JAK2 (IC50: 0.7 nM) and FLT3 (IC50: 4 nM) that demonstrates anticancer effects, also affecting JAK1 (IC50: 26 nM) and JAK3 (IC50: 39 nM). Target: Others
MW: 581.61 D
From 2,010.00€ *
Review
SSTR5 antagonist 2 hydrochloride
SSTR5 antagonist 2 hydrochloride

Item number: TGM-T64119-100mg

Description: SSTR5 antagonist 2 hydrochloride is a potent, orally active, selective antagonist of the growth hormone inhibitory hormone (receptor) subtype 5 (SSTR5), with potential for investigation in type 2 diabetes. Target: Others
MW: 583.09 D
From 1,450.00€ *
Review
SETDB1-TTD-IN-1 TFA
SETDB1-TTD-IN-1 TFA

Item number: TGM-T64120-25mg

Description: SETDB1-TTD-IN-1 TFA is a potent, selective, endogenous binding agent-competitive inhibitor of SETDB1-TTD (Kd: 88 nM), suitable for studying SETDB1-TTD-associated biological functions and diseases. Target: Others
MW: 583.6 D
From 1,782.00€ *
Review
12272 from 12310 pages